|
1
|
Urick ME and Bell DW: Clinical
actionability of molecular targets in endometrial cancer. Nat Rev
Cancer. 19:510–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colombo N, Preti E, Landoni F, Carinelli
S, Colombo A, Marini C and Sessa C; ESMO Guidelines Working Group,
: Endometrial cancer: ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 24 (Suppl
6):vi33–vi38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amant F, Mirza MR, Koskas M and Creutzberg
CL: Cancer of the corpus uteri. Int J Gynaecol Obstet. 143 (Suppl
2):S37–S50. 2018. View Article : Google Scholar
|
|
4
|
Saso S, Chatterjee J, Georgiou E, Ditri
AM, Smith JR and Ghaem-Maghami S: Endometrial cancer. BMJ.
343:d39542011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tangjitgamol S, Anderson BO, See HT,
Lertbutsayanukul C, Sirisabya N, Manchana T, Ilancheran A, Lee KM,
Lim SE, Chia YN, et al: Management of endometrial cancer in Asia:
Consensus statement from the Asian Oncology Summit 2009. Lancet
Oncol. 10:1119–1127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morice P, Leary A, Creutzberg C,
Abu-Rustum N and Darai E: Endometrial cancer. Lancet.
387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tanaka K, Kobayashi Y, Sugiyama J,
Yamazaki T, Dozono K, Watanabe M, Shibuya H, Nishigaya Y, Momomura
M, Matsumoto H, et al: Histologic grade and peritoneal cytology as
prognostic factors in type 1 endometrial cancer. Int J Clin Oncol.
22:533–540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sorosky JI: Endometrial cancer. Obstet
Gynecol. 120:383–397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Odagiri T, Watari H, Kato T, Mitamura T,
Hosaka M, Sudo S, Takeda M, Kobayashi N, Dong P, Todo Y, et al:
Distribution of lymph node metastasis sites in endometrial cancer
undergoing systematic pelvic and para-aortic lymphadenectomy: A
proposal of optimal lymphadenectomy for future clinical trials. Ann
Surg Oncol. 21:2755–2761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reijnen C, IntHout J, Massuger LFAG,
Strobbe F, Küsters-Vandevelde HVN, Haldorsen IS, Snijders MPLM and
Pijnenborg JMA: Diagnostic accuracy of clinical biomarkers for
preoperative prediction of lymph node metastasis in endometrial
carcinoma: A systematic review and meta-analysis. Oncologist.
24:e880–e890. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arend RC, Jones BA, Martinez A and
Goodfellow P: Endometrial cancer: Molecular markers and management
of advanced stage disease. Gynecol Oncol. 150:569–580. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Le Gallo M and Bell DW: The emerging
genomic landscape of endometrial cancer. Clin Chem. 60:98–110.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murali R, Delair DF, Bean SM, Abu-Rustum
NR and Soslow RA: Evolving roles of histologic evaluation and
molecular/genomic profiling in the management of endometrial
cancer. J Natl Compr Canc Netw. 16:201–209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Becker RM, Darrow C, Zimonjic DB, Popescu
NC, Watson MA and Fleming TP: Identification of mammaglobin B, a
novel member of the uteroglobin gene family. Genomics. 54:70–78.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao F, Mirwald A, Papaioannou M,
Baniahmad A and Klug J: Secretoglobin 2A1 is under selective
androgen control mediated by a peculiar binding site for Sp family
transcription factors. Mol Endocrinol. 19:2964–2978. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bellone S, Tassi R, Betti M, English D,
Cocco E, Gasparrini S, Bortolomai I, Black JD, Todeschini P, Romani
C, et al: Mammaglobin B (SCGB2A1) is a novel tumour antigen highly
differentially expressed in all major histological types of ovarian
cancer: Implications for ovarian cancer immunotherapy. Br J Cancer.
109:462–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dieters-Castator DZ, Rambau PF, Kelemen
LE, Siegers GM, Lajoie GA, Postovit LM and Köbel M:
Proteomics-derived biomarker panel improves diagnostic precision to
classify endometrioid and high-grade serous ovarian carcinoma. Clin
Cancer Res. 25:4309–4319. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tassi RA, Bignotti E, Rossi E, Falchetti
M, Donzelli C, Calza S, Ravaggi A, Bandiera E, Pecorelli S and
Santin AD: Overexpression of mammaglobin B in epithelial ovarian
carcinomas. Gynecol Oncol. 105:578–585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tassi RA, Calza S, Ravaggi A, Bignotti E,
Odicino FE, Tognon G, Donzelli C, Falchetti M, Rossi E, Todeschini
P, et al: Mammaglobin B is an independent prognostic marker in
epithelial ovarian cancer and its expression is associated with
reduced risk of disease recurrence. BMC Cancer. 9:2532009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fischer K, von Brünneck AC, Hornung D,
Denkert C, Ufer C, Schiebel H, Kuhn H and Borchert A: Differential
expression of secretoglobins in normal ovary and in ovarian
carcinoma-overexpression of mammaglobin-1 is linked to tumor
progression. Arch Biochem Biophys. 547:27–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tassi RA, Bignotti E, Falchetti M, Calza
S, Ravaggi A, Rossi E, Martinelli F, Bandiera E, Pecorelli S and
Santin AD: Mammaglobin B expression in human endometrial cancer.
Int J Gynecol Cancer. 18:1090–1096. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McCluggage WG: Pathologic staging of
endometrial carcinomas: Selected areas of difficulty. Adv Anat
Pathol. 25:71–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang BL, Li X, Liu P, Ma L, Wu W, Zhang
X, Li Z and Huang B: Transcriptomic analysis of Eruca vesicaria
subs. sativa lines with contrasting tolerance to polyethylene
glycol-simulated drought stress. BMC Plant Biol. 19:4192019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hua J, Shi S, Xu J, Wei M, Zhang Y, Liu J,
Zhang B and Yu X: Expression patterns and prognostic value of DNA
damage repair proteins in resected pancreatic neuroendocrine
neoplasms. Ann Surg. Mar 20–2020.(Epub ahead of print). View Article : Google Scholar
|
|
29
|
Mercatali L, Valenti V, Calistri D,
Calpona S, Rosti G, Folli S, Gaudio M, Frassineti GL, Amadori D and
Flamini E: RT-PCR determination of maspin and mammaglobin B in
peripheral blood of healthy donors and breast cancer patients. Ann
Oncol. 17:424–428. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aihara T, Fujiwara Y, Miyake Y, Okami J,
Okada Y, Iwao K, Sugita Y, Tomita N, Sakon M, Shiozaki H and Monden
M: Mammaglobin B gene as a novel marker for lymph node
micrometastasis in patients with abdominal cancers. Cancer Lett.
150:79–84. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bartosch C, Lopes JM and Jeronimo C:
Epigenetics in endometrial carcinogenesis-part 1: DNA methylation.
Epigenomics. 9:737–755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bignotti E, Tassi RA, Calza S, Ravaggi A,
Rossi E, Donzelli C, Todeschini P, Romani C, Bandiera E, Zanotti L,
et al: Secretoglobin expression in ovarian carcinoma: Lipophilin B
gene upregulation as an independent marker of better prognosis. J
Transl Med. 11:1622013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang CY, Liao KW, Chou CH, Shrestha S,
Yang CD, Chiew MY, Huang HT, Hong HC, Huang SH, Chang TH and Huang
HD: Pilot study to establish a novel five-gene biomarker panel for
predicting lymph node metastasis in patients with early stage
endometrial cancer. Front Oncol. 9:15082019. View Article : Google Scholar : PubMed/NCBI
|
